Risks and benefits of pediatric bone marrow donation: a critical need for research

V Weisz1, J K Robbennolt

  • 1University of Nebraska-Lincoln, Center on Children, Families, and the Law 68588-0227, USA. vweisz@unlinfo.unl.edu

Insights

Children donating bone marrow to siblings face minimal risks, but their well-being depends on recipient survival, donor age, and involvement in the decision. Further research is crucial to protect child donors.

Area of Science:

  • Pediatric Hematology
  • Child Psychology
  • Bioethics

Background:

  • Healthcare providers often assume minimal risks and potential psychosocial benefits for pediatric bone marrow donors.
  • Ethical justifications for using children as donors hinge on the premise of minimal risk, as they receive no direct medical benefit.
  • Empirical research on the psychosocial consequences for child bone marrow donors is limited.

Purpose of the Study:

  • To review existing research on the psychosocial outcomes for children undergoing bone marrow harvest for critically ill siblings.
  • To identify factors influencing the psychosocial impact on child bone marrow donors.
  • To highlight the need for direct empirical research to protect donor well-being.

Main Methods:

  • Literature review examining psychosocial outcomes in tissue and organ donation.
  • Analysis of research on the psychosocial impact on siblings of pediatric cancer patients.
  • Review of studies on children's decision-making in medical contexts.

Main Results:

  • Psychosocial impact on a child bone marrow donor is influenced by recipient survival, donor age, and donor participation in the decision-making process.
  • Existing literature suggests a complex interplay of factors affecting the child donor's experience.
  • The survival of the recipient is a significant factor in the donor's psychosocial outcome.

Conclusions:

  • Direct empirical research is necessary to accurately assess and validate the psychosocial risks and benefits for child bone marrow donors.
  • Ensuring the well-being of child donors requires a deeper understanding of their experiences.
  • Ethical considerations necessitate robust data on the psychosocial impact to protect vulnerable child donors.

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...